As a novel determinant of NDD, OFP was proposed to be distinct from the canonical, BRCA2-and Fanconi Anemia pathway-dependent fork protection (FP) pathway (Thakar et al., 2020; Cong et al., 2021; Thakar and Moldovan, 2021). The gene discussed is BRCA2; the disease is Fanconi anemia.